Avricore Health (AVCRF) Return on Capital Employed (2012 - 2025)
Avricore Health (AVCRF) posted quarterly Return on Capital Employed of 177.8% for Q4 2025, down 134.99% quarter-over-quarter from 75.66% in Q3 2025.
Avricore Health (AVCRF) Return on Capital Employed (2012 - 2025) Analysis & Trends
Avricore Health (AVCRF) has reported Return on Capital Employed for 14 consecutive years, with 177.8% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Capital Employed changed N/A year-over-year to 177.8%; the TTM figure through Dec 2025 stood at 177.8% (changed N/A YoY), while the FY2025 annual figure was 108.01%, down 11407.0% from the prior year.
- Return on Capital Employed declined to 177.8% in Q4 2025 per AVCRF's latest filing, from 75.66% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 11.64% in Q3 2024 and bottomed at 177.8% in Q4 2025.
- Historically, Return on Capital Employed has averaged 27.26% across 5 years, with a median of 17.27% in 2022.
- Annual changes were most pronounced in 2021 — Return on Capital Employed tumbled 15318 bps — and 2024, when it surged 5397 bps.
- Avricore Health's Return on Capital Employed stood at 8.16% in 2021, then tumbled by 373 bps to 38.57% in 2022, then jumped by 48 bps to 20.2% in 2023, then jumped by 158 bps to 11.64% in 2024, then slumped by 1627 bps to 177.8% in 2025.
- Business Quant data shows AVCRF's Return on Capital Employed at 177.8% in Q4 2025, 75.66% in Q3 2025, and 27.95% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.85% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -177.80% |
| Sep 30, 2025 | -75.66% |
| Jun 30, 2025 | -27.95% |
| Mar 31, 2025 | 6.44% |
| Sep 30, 2024 | 11.64% |
| Jun 30, 2024 | 6.42% |
| Mar 31, 2024 | -16.58% |
| Dec 31, 2023 | -20.20% |
| Sep 30, 2023 | -42.33% |
| Jun 30, 2023 | -32.52% |
| Mar 31, 2023 | -26.95% |
| Dec 31, 2022 | -38.57% |
| Sep 30, 2022 | -28.88% |
| Jun 30, 2022 | -17.27% |
| Mar 31, 2022 | -8.11% |
| Dec 31, 2021 | -8.16% |
| Sep 30, 2021 | -6.85% |
| Jun 30, 2021 | -5.87% |
| Mar 31, 2021 | -8.80% |
| Dec 31, 2020 | 13.51% |